Mesalazine-induced bullous fixed drug eruption

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Salman, Andac
• dc.contributor.author Seckin Gencosmanoglu, Dilek
• dc.contributor.author Ozen Alahdab, Yesim
• dc.contributor.author Giménez Arnau, Anna Maria
• dc.date.accessioned 2018-10-31T08:35:49Z
• dc.date.issued 2018
• dc.format.mimetype application/pdf
• dc.identifier.citation Salman A, Seckin Gencosmanoglu D, Alahdab YO, Giménez-Arnau AM. Mesalazine-induced bullous fixed drug eruption. Contact Dermatitis. 2018 Jul;79(1):34-35. DOI: 10.1111/cod.12972
• dc.identifier.doi http://dx.doi.org/10.1111/cod.12972
• dc.identifier.issn 0105-1873
• dc.identifier.uri http://hdl.handle.net/10230/35679
• dc.language.iso eng
• dc.publisher Wiley
• dc.relation.ispartof Contact Dermatitis. 2018 Jul;79(1):34-5
• dc.rights This is the peer reviewed version of the following article: Salman A, Seckin Gencosmanoglu D, Alahdab YO, Giménez-Arnau AM. Mesalazine-induced bullous fixed drug eruption. Contact Dermatitis. 2018 Jul;79(1):34-35, which has been published in final form at http://dx.doi.org/10.1111/cod.12972. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.subject.keyword 5-aminosalicylic acid
• dc.subject.keyword Case report
• dc.subject.keyword Fixed drug eruption
• dc.subject.keyword Mesalazine
• dc.subject.other Medicaments -- Efectes secundaris
• dc.title Mesalazine-induced bullous fixed drug eruption
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/acceptedVersion